Skip to main content
. 2022 Oct 31;109(4):297–304. doi: 10.1136/heartjnl-2022-321328

Table 2.

Demographic and clinical characteristics of the patients receiving double or triple combination treatment for recurrent pericarditis at baseline

Characteristic NSAID + colchicine
(n=24)
Colchicine + corticosteroid
(n=13)
Colchicine + corticosteroid + NSAID (n=18)
Age, years, mean (SD) 44.6 (13.41) 43.5 (16.4) 42.3 (14.7)
Age, years, no. (%)
 12–17 1.0 (4.2) 0 1.0 (5.6)
 18–64 22.0 (91.7) 12.0 (92.3) 17.0 (94.4)
 65–78 1.0 (4.2) 1.0 (7.7) 0
Female sex, no. (%) 19.0 (79.2) 7.0 (53.8) 11.0 (61.1)
Race*, no. (%)
 White 23.0 (95.8) 12.0 (92.3) 16.0 (88.9)
 Black/African American 1.0 (4.2) 0 2.0 (11.1)
 Other 0 1.0 (7.7) 0
Aetiology, no. (%)
 Idiopathic 20.0 (83.3) 9.0 (69.2) 15.0 (83.3)
 Postpericardiotomy syndrome 3.0 (12.5) 4.0 (30.8) 3.0 (16.7)
Dressler’s syndrome† 1.0 (4.2) 0 0
Duration of prior treatment with corticosteroids, weeks, mean (SD) 0 12.0 (17.7) 11.5 (25.4)
Total episodes, including index and qualifying, no., mean (SD) 4.8 (1.8) 4.2 (0.93) 4.5 (0.99)
Duration of disease, years, mean (SD) 3.6 (4.75) 1.0 (0.4) 1.4 (0.9)
Recurrent episodes per year, mean (SD) 3.8 (5.1) 5.5 (2.9) 5.6 (5.9)
Pain rating (qualifying episode), Numerical Rating Scale Score‡, mean (SD) 6.9 (1.9) 5.1 (1.3) 6.5 (1.7)
Standard C reactive protein (qualifying episode), mg/dL, mean (SD) 5.2 (6.4) 7.5 (7.3) 7.9 (7.4)
Pericarditis manifestations (qualifying episode), no. (%)
 Pericardial effusion§ no. (%) 6.0 (25.0) 7.0 (53.8) 7.0 (38.9)
 Pericardial rub, no. (%) 3.0 (12.5) 1.0 (7.7) 5.0 (27.8)
 ST elevation or PR depression, no. (%) 3.0 (12.5) 3.0 (23.1) 4.0 (22.2)
Pericarditis treatment at baseline, n (%)
Non-opioid analgesics 4.0 (16.7) 0 0
Opioid analgesics 4.0 (16.7) 0 0
Aspirin 2.0 (8.3) 0 1.0 (5.6)
Other NSAIDs¶ 22.0 (91.7) 0 17.0 (94.4)
Colchicine 24.0 (100) 13.0 (100) 18.0 (100)
Oral corticosteroids 0 13.0 (100) 18.0 (100)
Other 0 1.0 (7.7) 1 (5.6)

*Race was reported by patient.

†The cause of the Dressler syndrome was catheter ablation for atrial fibrillation.

‡Scores on the Numerical Rating Scale for pain range from 0 to 10, with higher scores indicating greater pain severity.

§Pericardial effusion was defined as new or worsening pericardial effusion, independent of the imaging method.

¶Non-steroidal anti-inflammatory drugs.